|
1
|
Takeda T: Senescence-accelerated mouse
(SAM): A biogerontological resource in aging research. Neurobiol
Aging. 20:105–110. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morley JE, Armbrecht HJ, Farr SA and Kumar
VB: The senescence accelerated mouse (SAMP8) as a model for
oxidative stress and Alzheimer's disease. Biochim Biophys Acta.
1822:650–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morley JE, Kumar VB, Bernardo AE, Farr SA,
Uezu K, Tumosa N and Flood JF: Beta-amyloid precursor polypeptide
in SAMP8 mice affects learning and memory. Peptides. 21:1761–1767.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Canudas AM, Gutierrez-Cuesta J, Rodriguez
MI, Acuña-Castroviejo D, Sureda FX, Camins A and Pallàs M:
Hyperphosphorylation of microtubule-associated protein tau in
senescence-accelerated mouse (SAM). Mech Ageing Dev. 126:1300–1304.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de la Monte SM and Tong M: Brain metabolic
dysfunction at the core of Alzheimer's disease. Biochem Pharmacol.
88:548–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aberg ND, Brywe KG and Isgaard J: Aspects
of growth hormone and insulin-like growth factor-I related to
neuroprotection, regeneration, and functional plasticity in the
adult brain. ScientificWorldJournal. 6:53–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kleinridders A, Ferris HA, Cai W and Kahn
CR: Insulin action in brain regulates systemic metabolism and brain
function. Diabetes. 63:2232–2243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cole GM and Frautschy SA: The role of
insulin and neurotrophic factor signaling in brain aging and
Alzheimer's Disease. Exp Gerontol. 42:10–21. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reger MA, Watson GS, Frey WH II, Baker LD,
Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR,
Schellenberg GD, et al: Effects of intranasal insulin on cognition
in memory-impaired older adults: modulation by APOE genotype.
Neurobiol Aging. 27:451–458. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moloney AM, Griffin RJ, Timmons S,
O'Connor R, Ravid R and O'Neill C: Defects in IGF-1 receptor,
insulin receptor and IRS-1/2 in Alzheimer's disease indicate
possible resistance to IGF-1 and insulin signalling. Neurobiol
Aging. 31:224–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Biessels GJ and Reagan LP: Hippocampal
insulin resistance and cognitive dysfunction. Nat Rev Neurosci.
16:660–671. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hardie DG: AMPK-sensing energy while
talking to other signaling pathways. Cell Metab. 20:939–952. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weisová P, Dávila D, Tuffy LP, Ward MW,
Concannon CG and Prehn JH: Role of 5′-adenosine
monophosphate-activated protein kinase in cell survival and death
responses in neurons. Antioxid Redox Signal. 14:1863–1876. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Zhou K, Wang R, Liu Y, Kwak YD, Ma
T, Thompson RC, Zhao Y, Smith L, Gasparini L, et al: Antidiabetic
drug metformin (GlucophageR) increases biogenesis of Alzheimer's
amyloid peptides via up-regulating BACE1 transcription. Proc Natl
Acad Sci USA. 106:3907–3912. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vingtdeux V, Davies P, Dickson DW and
Marambaud P: AMPK is abnormally activated in tangle- and
pre-tangle-bearing neurons in Alzheimer's disease and other
tauopathies. Acta Neuropathol. 121:337–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thornton C, Bright NJ, Sastre M, Muckett
PJ and Carling D: AMP-activated protein kinase (AMPK) is a tau
kinase, activated in response to amyloid beta-peptide exposure.
Biochem J. 434:503–512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vingtdeux V, Chandakkar P, Zhao H,
d'Abramo C, Davies P and Marambaud P: Novel synthetic
small-molecule activators of AMPK as enhancers of autophagy and
amyloid-β peptide degradation. FASEB J. 25:219–231. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai Z, Li B, Li K and Zhao B:
Down-regulation of amyloid-β through AMPK activation by inhibitors
of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 cells. J Alzheimers Dis.
29:89–98. 2012.PubMed/NCBI
|
|
19
|
Greco SJ, Sarkar S, Casadesus G, Zhu X,
Smith MA, Ashford JW, Johnston JM and Tezapsidis N: Leptin inhibits
glycogen synthase kinase-3beta to prevent tau phosphorylation in
neuronal cells. Neurosci Lett. 455:191–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim J, Park YJ, Jang Y and Kwon YH: AMPK
activation inhibits apoptosis and tau hyperphosphorylation mediated
by palmitate in SH-SY5Y cells. Brain Res. 1418:42–51. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim B, Figueroa-Romero C, Pacut C, Backus
C and Feldman EL: Insulin resistance prevents AMPK-induced tau
dephosphorylation through Akt-mediated increase in AMPKSer-485
phosphorylation. J Biol Chem. 290:19146–19157. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Culmsee C, Monnig J, Kemp BE and Mattson
MP: AMP-activated protein kinase is highly expressed in neurons in
the developing rat brain and promotes neuronal survival following
glucose deprivation. J Mol Neurosci. 17:45–58. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chan KH, Lam KS, Cheng OY, Kwan JS, Ho PW,
Cheng KK, Chung SK, Ho JW, Guo VY and Xu A: Adiponectin is
protective against oxidative stress induced cytotoxicity in
amyloid-beta neurotoxicity. PLoS One. 7:e523542012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dulovic M, Jovanovic M, Xilouri M,
Stefanis L, Harhaji-Trajkovic L, Kravic-Stevovic T, Paunovic V,
Ardah MT, El-Agnaf OM, Kostic V, et al: The protective role of
AMP-activated protein kinase in alpha-synuclein neurotoxicity in
vitro. Neurobiol Dis. 63:1–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cuesta S, Kireev R, Garcia C, Rancan L,
Vara E and Tresguerres JA: Melatonin can improve insulin resistance
and aging-induced pancreas alterations in senescence-accelerated
prone male mice (SAMP8). Age (Dordr). 35:659–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu HW, Chan YC, Wang MF, Wei CC and Chang
SJ: Dietary (−)-epigallocatechin-3-gallate supplementation
counteracts aging-associated skeletal muscle insulin resistance and
fatty liver in senescence-accelerated mouse. J Agric Food Chem.
63:8407–8417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim HS, Moon S, Paik JH, Shin DW, Kim LS,
Park CS, Ha J and Kang JH: Activation of the 5′-AMP-activated
protein kinase in the cerebral cortex of young
senescence-accelerated P8 mice and association with GSK3β- and
PP2A-dependent inhibition of p-tau396 expression. J
Alzheimers Dis. 46:249–259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo JL, Covell DJ, Daniels JP, Iba M,
Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ and
Lee VM: Distinct α-synuclein strains differentially promote tau
inclusions in neurons. Cell. 154:103–117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Giasson BI, Forman MS, Higuchi M, Golbe
LI, Graves CL, Kotzbauer PT, Trojanowski JQ and Lee VM: Initiation
and synergistic fibrillization of tau and alpha-synuclein. Science.
300:636–640. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morley JE, Farr SA, Kumar VB and Armbrecht
HJ: The SAMP8 mouse: A model to develop therapeutic interventions
for Alzheimer's disease. Curr Pharm Des. 18:1123–1130. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de la Monte SM: Brain insulin resistance
and deficiency as therapeutic targets in Alzheimer's disease. Curr
Alzheimer Res. 9:35–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pallàs M, Pizarro JG, Gutierrez-Cuesta J,
Crespo-Biel N, Alvira D, Tajes M, Yeste-Velasco M, Folch J, Caudas
AM, Sureda FX, et al: Modulation of SIRT1 expression in different
neurodegenerative models and human pathologies. Neuroscience.
154:1388–1397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Long YC, Cheng Z, Copps KD and White MF:
Insulin receptor substrates Irs1 and Irs2 coordinate skeletal
muscle growth and metabolism via the Akt and AMPK pathways. Mol
Cell Biol. 31:430–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Burkewitz K, Zhang Y and Mair WB: AMPK at
the nexus of energetics and aging. Cell Metab. 20:10–25. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ruderman NB, Xu XJ, Nelson L, Cacicedo JM,
Saha AK, Lan F and Ido Y: AMPK and SIRT1: A long-standing
partnership? Am J Physiol Endocrinol Metab. 298:E751–E760. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ruderman NB, Carling D, Prentki M and
Cacicedo JM: AMPK, insulin resistance, and the metabolic syndrome.
J Clin Invest. 123:2764–2772. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park H, Kam TI, Kim Y, Choi H, Gwon Y, Kim
C, Koh JY and Jung YK: Neuropathogenic role of adenylate kinase-1
in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Hum Mol
Genet. 21:2725–2737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu YY, He SS, Wang X, Duan QH,
Grundke-Iqbal I, Iqbal K and Wang J: Levels of nonphosphorylated
and phosphorylated tau in cerebrospinal fluid of Alzheimer's
disease patients: An ultrasensitive bienzyme-substrate-recycle
enzyme-linked immunosorbent assay. Am J Pathol. 160:1269–1278.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanger DP, Anderton BH and Noble W: Tau
phosphorylation: The therapeutic challenge for neurodegenerative
disease. Trends Mol Med. 15:112–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ramamurthy S, Chang E, Cao Y, Zhu J and
Ronnett GV: AMPK activation regulates neuronal structure in
developing hippocampal neurons. Neuroscience. 259:13–24. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin CL, Cheng YS, Li HH, Chiu PY, Chang
YT, Ho YJ and Lai TJ: Amyloid-β suppresses AMP-activated protein
kinase (AMPK) signaling and contributes to α-synuclein-induced
cytotoxicity. Exp Neurol. 275:84–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
